Brief: Briacell Therapeutics Announces Closing Of $13.8 Million Public Offering
28/04/2025 21:10
April 28 (Reuters) - Briacell Therapeutics Corp BCT.TO: BRIACELL THERAPEUTICS ANNOUNCES CLOSING OF $13.8 MILLION PUBLIC OFFERING Source text: ID:nGNX96m6J2 Further company coverage: BCT.TO (Reuters.Briefs@thomsonreuters.com)
Recent news on Briacell Therapeutics
See all newsBrief: Briacell Therapeutics Prices 1.45 Million Common Shares At $3.25 Per Share
Brief: Briacell Receives Positive Recommendation From Data Safety Monitoring Board (Dsmb) For Phase 3 Study In Metastatic Breast Cancer
Brief: Briacell Expands Pipeline To Include An Ovarian Cancer Immunotherapy Candidate, Bria-Ova+™
Brief: Briacell Phase 3 Bria-Imt™ Study Enrollment Surpasses 230 Patients
Brief: Briacell Adds Nyu Langone Health’S Perlmutter Cancer Center As Clinical Site In Pivotal Phase 3 Breast Cancer Study